It is estimated that more than two million cases of basal cell or squamous skin cancer (nonmelanoma) and 68,720 cases of malignant melanoma (the most serious form of skin cancer) were diagnosed in 2009 in the U.S.
Combination antibody therapy shows promise in metastatic melanoma (Science Daily)
A duo of monoclonal antibodies -- ipilimumab and bevacizumab -- each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial.
- About Us
- Skin Cancer
- Member Section